Follow
Michael W. Fried
Michael W. Fried
Professor of Medicine, University of North Carolina
Verified email at med.unc.edu
Title
Cited by
Cited by
Year
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection
MW Fried, ML Shiffman, KR Reddy, C Smith, G Marinos, FL Gonšales Jr, ...
New England journal of medicine 347 (13), 975-982, 2002
86442002
Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
GKK Lau, T Piratvisuth, KX Luo, P Marcellin, S Thongsawat, G Cooksley, ...
New England Journal of Medicine 352 (26), 2682-2695, 2005
20012005
Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis
KV Kowdley, SC Gordon, KR Reddy, L Rossaro, DE Bernstein, E Lawitz, ...
New England Journal of Medicine 370 (20), 1879-1888, 2014
15042014
A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness
L Stuyver, S De Gendt, C Van Geyt, F Zoulim, M Fried, RF Schinazi, ...
Journal of general virology 81 (1), 67-74, 2000
14942000
Side effects of therapy of hepatitis C and their management
MW Fried
Hepatology 36 (S1), S237-S244, 2002
12682002
Response-guided telaprevir combination treatment for hepatitis C virus infection
KE Sherman, SL Flamm, NH Afdhal, DR Nelson, MS Sulkowski, ...
New England Journal of Medicine 365 (11), 1014-1024, 2011
10462011
Sofosbuvir and velpatasvir for HCV in patients with decompensated cirrhosis
MP Curry, JG O’Leary, N Bzowej, AJ Muir, KM Korenblat, JM Fenkel, ...
New England Journal of Medicine 373 (27), 2618-2628, 2015
9622015
Ledipasvir and sofosbuvir plus ribavirin for treatment of HCV infection in patients with advanced liver disease
M Charlton, GT Everson, SL Flamm, P Kumar, C Landis, RS Brown Jr, ...
Gastroenterology 149 (3), 649-659, 2015
9492015
Oral direct-acting agent therapy for hepatitis C virus infection: a systematic review
O Falade-Nwulia, C Suarez-Cuervo, DR Nelson, MW Fried, JB Segal, ...
Annals of internal medicine 166 (9), 637-648, 2017
7372017
Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B
R McKenzie, MW Fried, R Sallie, H Conjeevaram, AM Di Bisceglie, Y Park, ...
New England Journal of Medicine 333 (17), 1099-1105, 1995
7271995
Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin
P Ferenci, MW Fried, ML Shiffman, CI Smith, G Marinos, FL Gonšales Jr, ...
Journal of hepatology 43 (3), 425-433, 2005
6752005
Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomisedá…
IM Jacobson, GJ Dore, GR Foster, MW Fried, M Radu, VV Rafalsky, ...
The Lancet 384 (9941), 403-413, 2014
6332014
Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1
HS Conjeevaram, MW Fried, LJ Jeffers, NA Terrault, TE Wiley–Lucas, ...
Gastroenterology 131 (2), 470-477, 2006
6002006
Liver transplantation for acute liver failure from drug induced liver injury in the United States
MW Russo, JA Galanko, R Shrestha, MW Fried, P Watkins
Liver Transplantation 10 (8), 1018-1023, 2004
6002004
Efficacy and safety of pegylated (40-kd) interferon α-2a compared with interferon α-2a in noncirrhotic patients with chronic hepatitis C
KR Reddy, TL Wright, PJ Pockros, M Shiffman, G Everson, R Reindollar, ...
Hepatology 33 (2), 433-438, 2001
5312001
Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to human immunodeficiency virus infection and liver disease. Multicenter Hemophilia Cohort Study
ME Eyster, MW Fried, AM Di Bisceglie, JJ Goedert
4901994
Ribavirin as therapy for chronic hepatitis C: a randomized, double-blind, placebo-controlled trial
AM Di Bisceglie, HS Conjeevaram, MW Fried, R Sallie, Y Park, ...
Annals of internal medicine 123 (12), 897-903, 1995
4781995
Once‐daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment‐naive genotype 1 hepatitis C: the randomized PILLAR study
MW Fried, M Buti, GJ Dore, R Flisiak, P Ferenci, I Jacobson, P Marcellin, ...
Hepatology 58 (6), 1918-1929, 2013
3772013
A pilot study of ribavirin therapy for chronic hepatitis C
AM di Bisceglie, M Shindo, TL Fong, MW Fried, MG Swain, NV Bergasa, ...
Hepatology 16 (3), 649-654, 1992
3771992
Side effects of therapy for chronic hepatitis C
MW Russo, MW Fried
Gastroenterology 124 (6), 1711-1719, 2003
3632003
The system can't perform the operation now. Try again later.
Articles 1–20